Back

Knockout of purinergic receptor Y13 (P2Y13) results in an improved outcome in metabolic syndrome in mice

3 September 2019 (11:30 - 11:45)
Organised by:
Congress Presentation Part of: Metabolic interfaces in vascular disease Lipid Metabolism, Metabolic Syndrome, Diabetes ESC Premium Access ESC Congress 2019

About the speaker

Photo
Mr Julian Merz

University of Freiburg, Freiburg (Germany)

5 More presentations in this session

Presentation thumbnail
A novel senolytic drug, seno-7284 ameliorates age-related cardiometabolic diseases
Doctor G. Katsuumi (Tokyo, JP)
Abstract Slides Video
Presentation thumbnail
Maternal high-fat diet exaggerates the development of diet-induced insulin resistance in adult offspring by enhancing pyroptosis through augmented gasdermin D-mediated pore formation
Doctor N. Wada (Kyoto, JP)
Abstract Slides Video
Presentation thumbnail
A distinct LDL profile to predict the risk of cardiovascular disease in familial hypercholesterolemia subjects: initial pre-clinical results
Miss A. Hoogendoorn (Adelaide, AU)
Abstract
Presentation thumbnail
Endothelial mitochondrial fragmentation contributes to vascular dysfunction in hypertension
Associate Professor X. Zhang (Xi'an, CN)
Presentation thumbnail
Endothelial autophagy triggers nuclear enrichment of miR-126-5p via a Mex3a-dependent pathway to confers endothelial protection and prevent atherosclerosis.
Doctor D. Santovito (Munich, DE)
Abstract

Access the full session

Session thumbnail
Metabolic interfaces in vascular disease

The Event

Event poster

ESC Congress 2019

3 September 2019 11:30 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources